Abstract Search

ea0011p179 | Clinical practise and governance | ECE2006

Improvements for patients and nurses using 2.5 ml prefilled syringes as the vehicle solution for suspension of Sandostatin LAR^® microspheres

Maher KT , Drake WM , Besser GM , Grossman AB , Chew SL , Jenkins PJ , Kalingag LA , Fode FK , O’Sullivan-Hawketts MT , Walker DM , Monson JP

The preparation of Sandostatin LAR® injections using a 2 ml ampoule of vehicle solution may be associated with some technical difficulties of administration, with adverse consequences for patients. The development of a 2.5 ml prefilled syringe may alleviate some of these problems. We have compared these two methods of Sandostatin LAR® administration in 17 patients with acromegaly and 5 patients with neuro-endocrine tumours, (6 drug naïve, 1...

0 shares

Endocrine Abstracts

Improvements for patients and nurses using 2.5 ml prefilled syringes as the vehicle solution for suspension of Sandostatin LAR^® microspheres

BiosciAbstracts

Endocrine Abstracts

Improvements for patients and nurses using 2.5 ml prefilled syringes as the vehicle solution for suspension of Sandostatin LAR® microspheres

BiosciAbstracts

Improvements for patients and nurses using 2.5 ml prefilled syringes as the vehicle solution for suspension of Sandostatin LAR^® microspheres